Preview

Medical Immunology (Russia)

Advanced search

THE GROUNDS OF CLARITROMYCIN USE IN THE TREATMENT OF PSORIASIS

https://doi.org/10.15789/1563-0625-2005-4-405-410

Abstract

Abstract. Claritromycin influence on the keratinocytes proliferation and differentiation and lymphocytes proliferation and clasters of differentiation expression in vitro was investigated. It was established that claritromycin in dose 2 mkg/ml inhibited psoriatic keratinocytes proliferation and increased its differentiation degree in culture. Claritromycin influence was mediated by CD4+ lymphocytes. Furthermore, claritromycin in vitro decreased the number of СD25+ lymphocytes and spontaneous and PHA-induced lymphocytes proliferation for psoriatic patients. These data allow to include claritromycin in the treatment regimen of psoriasis.

About the Author

V. L. Rybkina
Научно–исследовательский кожно–венерологический институт МЗ
Kazakhstan


References

1. Иммунологические методы / под ред. Г. Фримеля. — М. : Медицина, 1987. -314 с.

2. Adamicova K., Fetisovova Z., Cingel P. Quantitative changes in CD4+ and CD8+ T-lymphocyte in skin of patients with psoriasis treated with cyclosporine A // Cesc Patol. — 2001.-Vol. 37.-№4.-P. 154 -157.

3. Bos J.D. Immunocompetent cells in psoriasis: in situ immunophenotyping by monoclonal antibodies // Arch Dermatol Res.-1983.-Vol.-275.-P.181-189.

4. Boyum A: Isolation of mononuclear cells and granulocytes from human blood//Scand. J. Clin. Lab. Invest. -1988. -Vol. 2.-N3.-P. 77-89.

5. Chang J.I., Smith L.R., Froning K.J. Persistence of T -cell clones in psoriatic lesions//Arch Dermatol. -1997. -Vol. 133.-№ 6.-P. 703 -709.

6. Liu S.C., Eaton M.G., Karasek M. Growth characteristics of human epidermal keratinocytes from newborn foreskins in primary and serial cultures//In vitro. — 1979.-Vol.15.-P. 813-821.

7. Leyra A., Jr. Kelley W. N. Measurement of DNA in cultured human cells//Anal biochem. -1974. -Vol. 62.-№5. -P. 173-179.

8. Mac Leod C.M. Novel claritromycin research//Macrolides in the new Millenium: international consensus conference. -2000. -P. 35-39.

9. Morikawa C. J. Claritromycin influence on inflammatory cytokines roduction // J. Invest .Dermatol. -1998. -Vol.13. -N 7. — P. 14-18.

10. Rheinwald T.G., Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells//Cell. -1975. -Vol. 6.-№ 2. -P. 331 -344.

11. Spuls PI, Bossuyt PM, van Everlingen JJ, Witcamp L, Bos JD The development of practice guidelines for the treatment of severe plaque form psoriasis//Arch Dematol. -1998. -Vol. -134.-P.1591-1596.

12. Takeshita K., Yamagishi I., Harada M. Immunological and anti-inflammatory effects of clarythtomycine: inhibition of interleukin 1 production of murine peritoneal macrophages//Drugs Exp. Clin.Res.-1989. -Vol. 15. -P. 527-533.


Review

For citations:


Rybkina V.L. THE GROUNDS OF CLARITROMYCIN USE IN THE TREATMENT OF PSORIASIS. Medical Immunology (Russia). 2005;7(4):405-410. (In Russ.) https://doi.org/10.15789/1563-0625-2005-4-405-410

Views: 1159


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1563-0625 (Print)
ISSN 2313-741X (Online)